Mallinckrodt and Endo are exploring a potential merger that could be valued at about $7 billion, person familiar with the ...

LXP is a $2.7 billion REIT in the industrial sector. The company's focus is on buying, developing and operating high-quality, ...

The news sent Roche's stock up more than 4% in trading Wednesday, and Zealand's stock skyrocketed 40% on the news. Meanwhile, Novo Nordisk's stock was hit, sliding 4%, and Eli Lilly's stock was down ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...

We recently published an article titled Jim Cramer’s Latest Lightning Round: 8 Stocks in Focus. In this article, we are going ...

When a stock is in a freefall, there's usually a justifiable reason for the decline. But for investors with a high risk ...

Viking announced a supply deal with CordenPharma that sets it up for a standalone path to the obesity market. Read why I ...

Concentra Biosciences offers $3/share + CVR for Acelyrin, outperforming Alumis' bid. Read why I rate SLRN stock a Sell at ...

The US pharmaceutical sector is experiencing a distinct trend never seen before with large American pharma companies continually looking for medicines in China.

The best blue-chip stocks to buy for 2025 are more like the tortoise and less like the hare. The following 10 picks all offer ...

Trump said he would increase from 25% to 50% tariffs taking effect Wednesday for Canada after Ontario said it would raise ...